Device
AFO
AFO is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
terminated133%
completed267%
Recent Activity
Clinical Trials (3)
Showing 3 of 3 trials
NCT05587010
Comparison of Gait in Different Support Conditions for Foot Drop
NCT01796860Not Applicable
Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis
NCT00216320Not Applicable
Efficacy of the WalkAide and AFOs for CVA
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3